Cafepharma Today

January 16 2025 - The rise of China innovation in the time of Trump
The rise of China innovation in the time of Trump
Gilead settles with US government in long-running patent dust-up over PrEP meds
J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

The Rise of China Innovation in the Time of Trump
BioSpace
Thursday, January 16, 2025 - 11:22am
tags:
China, innovation, Donald Trump, trade
After Letter to Commissioner, FDA Finally Gives Vanda Reason for Rejection, Chance for Hearing
BioSpace
Thursday, January 16, 2025 - 11:21am
tags:
FDA, Robert Califf, Vanda Pharmaceuticals, tradipitant
JPM25: Emergent secures licensing deal for opioid overdose spray amid recovery plan
Fierce Pharma
Thursday, January 16, 2025 - 11:17am
tags:
JPMHC 2025, Emergent BioSolutions, opioid overdose, Kloxxado, Narcan
JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says
Fierce Pharma
Thursday, January 16, 2025 - 11:16am
tags:
Bayer, Xarelto, JPMHC 2025
Qiagen Receives FDA Clearance for First Mini Gastrointestinal Panel
Xtalks
Thursday, January 16, 2025 - 11:15am
tags:
Qiagen, Medtech, diagnostics, FDA, gastrointestinal disease
Google Cloud 'can't wait to see what's next' as Servier extends AI drug R&D pact
Fierce Biotech
Thursday, January 16, 2025 - 11:13am
tags:
Servier, Google Cloud, artificial intelligence
Sanofi to increase competition in atopic dermatitis market after Dupixent success
Clinical Trials Arena
Thursday, January 16, 2025 - 11:09am
tags:
Sanofi, KT-474, Kymera Therapeutics, atopic dermatitis, Dupixent
Gilead settles with US government in long-running patent dust-up over PrEP meds Truvada, Descovy
Fierce Pharma
Thursday, January 16, 2025 - 11:08am
tags:
Gilead Sciences, DOJ, HHS, patents, Truvada, Descovy, legal
OS Therapies’s HER2 therapy prevents lung cancer recurrence in 33% patients
Clinical Trials Arena
Thursday, January 16, 2025 - 11:06am
tags:
OS Therapies, lung cancer, HER2 Inhibitor
By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
Pharma Voice
Thursday, January 16, 2025 - 11:02am
tags:
JPMHC 2025, M&A, JNJ, Intra-Cellular Therapeutics, GSK, IDRx
Biopharma’s AI rally: Readiness not hype in 2025
Pharmaphorum
Thursday, January 16, 2025 - 11:01am
tags:
biotech, artificial intelligence
Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines
Yahoo Finance
Thursday, January 16, 2025 - 11:00am
tags:
Micron Biomedical, needle-free vaccines, vaccines, funding
JP Morgan 2025: AbbVie counts on Skyrizi and Rinvoq to fill Humira-sized hole
Clinical Trials Arena
Wednesday, January 15, 2025 - 11:54pm
tags:
JPMHC 2025, AbbVie, Skyrizi, Rinvoq, Humira
JPM25: Takeda spotlights 6 pipeline assets that could pull down up to $20B in collective peak sales
Fierce Pharma
Wednesday, January 15, 2025 - 11:52pm
tags:
Takeda, JPMHC 2025
Lilly's Omvoh scores second IBD win with FDA nod in Crohn's
First Word Pharma
Wednesday, January 15, 2025 - 11:50pm
tags:
Eli Lilly, Omvoh, IBD, FDA, Crohn's Disease
Federal watchdog cites concerns with FDA’s accelerated approval process
BioPharma Dive
Wednesday, January 15, 2025 - 11:48pm
tags:
HHS, FDA, accelerated approvals, Aduhelm, Biogen
Under pressure to deal, Biogen executives deflect urgency at JPM25
BioSpace
Wednesday, January 15, 2025 - 11:33am
tags:
Biogen, JPMHC 2025, M&A, Chris Viehbacher, SAGE Therapeutics
Boston Scientific ups PFA forecast, targets market leadership
Medtech Dive
Wednesday, January 15, 2025 - 11:21am
tags:
Boston Scientific, Medtech, JPMHC 2025, pulsed field ablation, PFA, Farapulse
Sling Therapeutics sees success reducing eye bulge in Phase IIb/III trial
Clinical Trials Arena
Wednesday, January 15, 2025 - 11:18am
tags:
Sling Therapeutics, clinical trials, thyroid eye disease, linsitinib
UnitedHealth investors await details behind 2025 outlook after exec's murder
Yahoo/Reuters
Wednesday, January 15, 2025 - 11:12am
tags:
UnitedHealth, earnings, Brian Thompson, insurers

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline
Inflation-Adjusted U.S. Brand-Name Drug Prices Fell for the Seventh Consecutive Year as a New Era of Drug Pricing Dawns
Drug Channels
Carbyne Remains Elusive
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information